- The FDA grants 510(k) clearance for Quidel's (NASDAQ:QDEL -0.5%) Solana Bordetella Complete Assay, a qualitative molecular diagnostic test for pertussis (whooping cough) and parapertussis.
- The company says the Solana instrument can process up to 12 samples per run.
FDA clears Quidel molecular test for whooping cough
Recommended For You
More Trending News
About QDEL Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
QDEL | - | - |
QuidelOrtho Corporation |